title: T-cell therapies for HIV.
abstract: Antiretroviral therapy has improved the quality of life for HIV(+) individuals but efficacy requires strict adherence and treatment is not curative. Recently, the use of T cells as therapeutic agents has been in the spotlight in the settings of post-transplant opportunistic infections and cancer. Whether T-cell therapy can be harnessed for treating HIV remains to be determined but there are a few studies that seek to answer that question. Infusion of ex vivo-expanded HIV-specific T cells showed limited efficacy but no adverse events. Genetically modified T cells expressing CD4 chimeric antigen receptors have recently been shown to have persistence that outperforms chimeric antigen receptors used for cancers. Although the results have not yet been published for many clinical studies using T cells for HIV, preclinical studies and the clinical data that are available highlight the potential for T-cell therapy to decrease or eliminate HIV patients' dependency on antiretroviral therapy.
authors.affiliation: Center for Cell & Gene Therapy, 1102 Bates Street, Ste 1770.01, Houston, TX 77030, USA.
authors.forename: Sharon
authors.initials: S
authors.lastname: Lam
authors.forename: Catherine
authors.initials: C
authors.lastname: Bollard
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000637:transplantation*; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive
chemical_list: D019380:Anti-HIV Agents; D015704:CD4 Antigens
references.citation: Sci Transl Med. 2012 May 2;4(132):132ra53
references.pmid: 22553251
references.citation: J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):152-61
references.pmid: 19593160
references.citation: J Virol. 2011 Oct;85(20):10518-28
references.pmid: 21835793
references.citation: Curr HIV Res. 2008 Jan;6(1):1-9
references.pmid: 18288969
references.citation: Cytotherapy. 2010 Oct;12(6):743-9
references.pmid: 20429793
references.citation: J Virol. 2002 May;76(9):4625-33
references.pmid: 11932428
references.citation: J Virol. 2012 Jun;86(12):6959-69
references.pmid: 22514340
references.citation: J Virol. 1994 Jul;68(7):4650-5
references.pmid: 8207839
references.citation: J Clin Oncol. 2010 Jul 1;28(19):3167-75
references.pmid: 20516446
references.citation: Clin Exp Immunol. 2009 Jan;155(1):44-52
references.pmid: 19016807
references.citation: J Virol. 2003 Feb;77(3):2081-92
references.pmid: 12525643
references.citation: Blood. 2010 Feb 4;115(5):925-35
references.pmid: 19880495
references.citation: J Virol. 2008 Apr;82(7):3561-73
references.pmid: 18234800
references.citation: N Engl J Med. 2009 Feb 12;360(7):692-8
references.pmid: 19213682
references.citation: Blood. 2000 Aug 1;96(3):785-93
references.pmid: 10910888
references.citation: Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007252
references.pmid: 22229122
references.citation: N Engl J Med. 2012 Jun 28;366(26):2455-65
references.pmid: 22658128
references.citation: J Immunol. 2010 Sep 1;185(5):2643-4
references.pmid: 20724729
references.citation: J Virol. 2009 Mar;83(6):2743-55
references.pmid: 19116253
references.citation: J Virol. 2000 May;74(10):4456-64
references.pmid: 10775581
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3390-5
references.pmid: 17360656
references.citation: Immunity. 1999 Jun;10(6):661-71
references.pmid: 10403641
references.citation: Trends Immunol. 2007 Dec;28(12):532-40
references.pmid: 17981085
references.citation: Blood. 2011 May 19;117(20):5391-402
references.pmid: 21422474
references.citation: Nat Med. 1995 Apr;1(4):330-6
references.pmid: 7585062
references.citation: Mol Ther. 2010 Apr;18(4):661-2
references.pmid: 20357776
references.citation: Blood. 1997 Sep 15;90(6):2196-206
references.pmid: 9310470
references.citation: Mol Ther. 2010 Feb;18(2):370-6
references.pmid: 19997090
references.citation: J Leukoc Biol. 2000 Sep;68(3):345-50
references.pmid: 10985250
references.citation: Nat Med. 2006 Oct;12(10):1160-6
references.pmid: 16998485
references.citation: Nature. 2006 Sep 21;443(7109):350-4
references.pmid: 16921384
references.citation: Mol Ther. 2012 Apr;20(4):849-59
references.pmid: 22273578
references.citation: Curr Opin HIV AIDS. 2011 Jan;6(1):74-9
references.pmid: 21242897
references.citation: J Virol. 2012 Sep;86(17):9351-60
references.pmid: 22718823
references.citation: Nature. 1999 Oct 14;401(6754):659-60
references.pmid: 10537102
references.citation: Mol Ther. 2002 Jun;5(6):788-97
references.pmid: 12027564
references.citation: J Exp Med. 2009 Jun 8;206(6):1253-72
references.pmid: 19487423
references.citation: J Clin Invest. 2008 Jan;118(1):294-305
references.pmid: 18060041
references.citation: N Engl J Med. 2011 Nov 3;365(18):1673-83
references.pmid: 22047558
references.citation: Nat Med. 1999 May;5(5):518-25
references.pmid: 10229228
references.citation: Nature. 1987 Jul 23-29;328(6128):345-8
references.pmid: 3496541
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81
references.pmid: 17428922
references.citation: Mol Ther. 2009 Dec;17(12):2103-14
references.pmid: 19690520
references.citation: Mol Ther. 2012 Sep;20(9):1800-9
references.pmid: 22588271
references.citation: Nat Med. 2008 Dec;14(12):1390-5
references.pmid: 18997777
references.citation: Eur J Immunol. 2012 May;42(5):1080-8
references.pmid: 22539281